Navigation Links
Protein May Help Spot Newborns With Brain Damage

FRIDAY, Oct. 14 (HealthDay News) -- Elevated blood levels of a central nervous system protein can help doctors identify newborns with brain injuries caused by a lack of oxygen, according to a new study.

Monitoring levels of "glial fibrillary acidic protein," or GFAP, can also help doctors assess the effectiveness of a body-cooling therapy meant to prevent permanent brain damage in these infants, Johns Hopkins researchers said.

GFAP is specific to central nervous system cells that are crucial to the brain's structure.

The Hopkins team examined GFAP levels in 23 newborns who were born between 36 and 41 weeks' gestation and diagnosed with clinical oxygen deficiency to the brain (hypoxic-ischemic encephalopathy, or HIE), and compared them to babies without brain injury who were born at the same length of gestation.

HIE affects one to eight newborns per 1,000 U.S. births and can cause death, developmental delays, mental retardation or cerebral palsy.

The researchers found that GFAP levels were significantly higher in newborns with brain damage caused by oxygen deficiency during the first week of life.

"GFAP, a circulating brain-specific protein, is already measured in adult patients after stroke, cardiac arrest or traumatic brain injury in an effort to provide a prognosis for survival or brain damage," Dr. Ernest M. Graham, an associate professor of gynecology and obstetrics and a maternal-fetal medicine expert, noted in a Hopkins news release.

"Now we know this biomarker can serve as a valid predictor of disease, injury evolution and outcome in newborns," he added.

The highest GFAP levels were found in infants who had abnormal MRI brain scans and who underwent whole-body cooling, a three-day treatment that lowers the body temperature to 92.3 degrees Fahrenheit.

"Even though cooling therapy decreases the risk of death and neurological damage in newborns, it is far from perfect therapy, and its effectiveness varies from baby to baby," co-investigator Dr. Allen Everett, a pediatric cardiologist at the Johns Hopkins Children's Center, said in the news release.

"We don't really know for sure if during the 72 hours of cooling the brain is actually recovering. Biomarkers like GFAP can remove that uncertainty by telling physicians how the brain is responding, allowing them to tailor treatments accordingly," Everett explained.

One expert agreed that it's often "difficult" to spot newborns at risk.

"Diagnosis of neonatal encephalopathy and identification of eligible patients for hypothermia therapy can be challenging," said Dr. Elena Wachtel, director of the Neonatal Comprehensive Care Program at NYU Langone Medical Center and Bellevue Hospital Center in New York City.

Wachtel, who also directs the hospital's Hypothermia Program, said the new study results contain "very important and exciting data." She said it might "assist neonatologists to accurately identify eligible infants for hypothermia therapy, measure treatment efficacy and assist in providing prognostic information to the families." However, "further research is needed to determine if GFAP level can also predict the long-term neurodevelopmental outcome," Wachtel added.

The study was published in a recent issue of the American Journal of Obstetrics & Gynecology.

More information has more about hypoxic-ischemic encephalopathy.

-- Robert Preidt

SOURCES: Elena Wachtel, M.D., M.P.H., director, Hypothermia Program and Neonatal Comprehensive Care Program, NYU Langone Medical Center and Bellevue Hospital Center, New York City; Johns Hopkins Medicine, news release, Oct. 13, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New and Delicious, Almond Butter Filled, Cookie Bites With 35.7% Protein to Help Manage Weight and Build Muscle
2. Research highlights role of protein pair in obesity regulation
3. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
4. Smithfield, United Food and Commercial Workers Union, and Food Networks Paula Deen to Deliver 150,000 Servings of Protein to San Francisco Food Bank
5. Protein Sciences Corporation Announces Profitable and Cash Flow Positive Results for 2009 and Management Realignment
6. Protein Appears Key to Intestinal Balance
7. SIBLING proteins may predict oral cancer
8. Damaged protein identified as early diagnostic biomarker for Alzheimers disease in healthy adults
9. Cells of aggressive leukemia hijack normal protein to grow
10. Omega Protein Comments on California Lawsuit Alleging Fish Oil Contaminants
11. Proteins May Predict Spread of Colon Cancer
Post Your Comments:
Related Image:
Protein May Help Spot Newborns With Brain Damage
(Date:10/12/2015)... , ... October 12, 2015 , ... Advera Health ... no charge to qualified Managed Care Organizations (MCOs) in order to provide health plans, ... into their decision making process. In addition, the DSM is also being offered to ...
(Date:10/12/2015)... ... October 12, 2015 , ... To ... announced its charitable donation to the National Breast Cancer Foundation. The National Breast ... by breast cancer through early detection, education, and support services. , The annual ...
(Date:10/12/2015)... ... ... Clara dentist , Dr. Alan Frame, shares his insight on today’s dental hygiene and the ... “I want each one of my patients to be at their optimum level of health, ... implants dentist , Dr. Frame. He mentions, "As the white paper mentions, oral health care ...
(Date:10/12/2015)... ... October 12, 2015 , ... ... receive a Eugene Washington Engagement Award by the Patient-Centered Outcomes Research Institute (PCORI) ... the research community. , The project, entitled “Training Patients with Asthma to ...
(Date:10/12/2015)... ... October 12, 2015 , ... ... secured a new corporate headquarters, located at 485 Madison Avenue, New York, NY ... and increased emphasis on cloud-based technology. , “Care to Care is a dynamic ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... 13, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... Cell Therapy Catapult to advance development of large ... cell immunotherapy. Under the agreement, the Cell Therapy ... AST-VAC2 to support advanced clinical trials and eventual ... --> The Cell Therapy Catapult is ...
(Date:10/12/2015)... 13, 2015 the United States ... a non-clinical capacity. --> the United States ... a non-clinical capacity. --> The University of Texas MD ... the first high field (1.5 Tesla) MRI-guided linear accelerator in ... system will be operating in a non-clinical capacity. Royal ...
(Date:10/12/2015)... 2015 Given the intricacy of the ... to deliver an ophthalmic drug effectively to a specific ocular ... ocular drug delivery. These include dilution of a drug by ... conjunctiva and drug permeation issues with respect to the cornea, ... eye drops, is lost due to the aforementioned barriers. ...
Breaking Medicine Technology: